Worldwide Needle Free Diabetes Management Industry to 2029 - by Device Type and Geography - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Needle Free Diabetes Management Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.

This report titled needle free diabetes management market studies various device types such as treatment devices, diagnostic devices and artificial pancreas that respectively sub-segmented. According to the International Diabetes Federation, in 2015 one in 11 adult has diabetes and by 2040 it is expected that one in 10 adults will have diabetes. The data suggests that in 2015 every 6 seconds one person dies from diabetes. Thus, diabetes management is one of the most crucial parts to prevent life threatening effects of this disease. The ongoing research and development activities in field of diagnosis and treatment of diabetes are expected to change the aspect of market in coming years.

For the purpose of this study, the global needle free diabetes management market on the basis of device type is segmented into treatment devices, diagnostic devices and artificial pancreas. Treatment devices comprise of insulin pens, pumps & patches, inhalers and jet injectors. Diagnosis devices are further sub-segmented as continuous glucose monitoring (CGM) device and flash glucose monitoring (FGM) system Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.

The needle free diabetes management market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2019 to 2029 and their CAGRs for the period 2021 to 2029 are provided in this report.

Companies Mentioned

• Zogenix Inc.
• 3M
• Antares Pharma Inc.
• Glide Pharmaceutical Technologies Ltd.
• Injex Pharma AG
• Pharmajet Inc.
• Bioject Medical Technologies Inc.
• Medtronic Inc.
• Johnson & Johnson Inc.
• Pancreum LLC
• Tandem Diabetes Care Inc.
• JDRF
• Akra Dermojet

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

2.1 Global Needle Free Diabetes Management Market, by Devices Type, 2020 v/s 2029 (Value %)

2.2 Global Needle Free Diabetes Management Market, by Geography, 2020 (Value %)

Chapter 3 Global Needle Free Diabetes Management Market Overview

3.1 Overview

3.2 Market Drivers

3.2.1 Increasing Prevalence Of Diabetes Due To Mounting Obesity And Sedentary Lifestyle In People

3.2.2 Growing Evolution and Success of Continuous Glucose Monitors

3.3 Market Restraints

3.3.1 Creating Quick Acting Insulin and Glucagon Formula

3.3.2 Regulatory Hurdles and Cost Constraints

3.4 Market Opportunities

3.4.1 Development of Next Generation Glucose Sensors

3.4.2 Intensive Investment in R&D Efforts

3.5 Attractive Investment Proposition

3.6 Market Competition Assessment: Needle Free Diabetes Management, by Key Players

3.6.1 Needle Free Diabetes Management Market, Key Players Analysis By Treatment Devices

3.6.2 Needle Free Diabetes Management Market, Key Players Analysis By Diagnostic Devices

Chapter 4 Global Needle Free Diabetes Management Market Analysis, By Device Type

4.1 Overview

4.2 Treatment Devices

4.2.1 Insulin Jet Injector

4.2.2 Insulin Pen

4.2.3 Insulin Inhaler

4.2.4 Insulin Patch & Pump

4.3 Diagnostic Devices

4.3.1 Continuous Glucose Monitoring (CGM) System

4.3.2 Flash Glucose Monitoring (FGM) System

4.4 Artificial Pancreas Devices & Systems

Chapter 5 Global Needle Free Diabetes Managements Transplantion Market, By Geography

5.1 Preface

5.2 North America

5.2.1 U.S.

5.2.2 Canada

5.3 Europe

5.3.1 U.K

5.3.2 Germany

5.3.3 Rest of Europe

5.4 Asia Pacific

5.4.1 Japan

5.4.2 China

5.4.3 Rest of Asia Pacific

5.5 Latin America

5.5.1 Brazil

5.5.2 Mexico

5.5.3 Rest of Latin America

5.6 Middle East and Africa

Chapter 6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/va4eq0